Starting with Exelixis’ condition on in-house dispensing data, manufacturers are introducing a new approach to 340B claims focused on transparency.
|Articles|January 12, 2004
Pharmacist interventions pay off, community R.Ph.s claim
Pharmacy trade groups put on a show about the value of pharmacist interventions
Advertisement
Advertisement
Related to this article
Advertisement
Advertisement
Trending on Drug Topics
1
Injectable HIV Treatment Beats Daily Pills in Adolescent Trial
2
Tozorakimab Reduces COPD Exacerbations in Phase 3 Trials
3
Muscle Preservation Is Key in GLP-1 Therapy for Postmenopausal Women
4
Pharmacy Law Lowdown: FDA’s Evaluation of Peptides
5